2018
DOI: 10.1016/j.jneuroim.2018.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Differential binding patterns of anti-sulfatide antibodies to glial membranes

Abstract: Sulfatide is a major glycosphingolipid in myelin and a target for autoantibodies in autoimmune neuropathies. However neuropathy disease models have not been widely established, in part because currently available monoclonal antibodies to sulfatide may not represent the diversity of anti-sulfatide antibody binding patterns found in neuropathy patients. We sought to address this issue by generating and characterising a panel of new anti-sulfatide monoclonal antibodies. These antibodies have sulfatide reactivity … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 50 publications
0
10
0
Order By: Relevance
“…To firmly establish that the observed disruptions to paranodal proteins were not partly a confounding consequence of structural dysfunction secondary to abnormal ganglioside profiles in the axonal compartment of transgenic Glial mice, a complement-fixing antibody against the myelin glycolipid sulfatide ( 27 ) was used to target the paranodal loop glial membrane in WT mice in order to look for similar perturbations. As seen with the anti-GM1 antibody in Glial mice, AnkB and Caspr1 immunostaining was lost/abnormal compared with uninjured control ( Supplemental Figure 4 ) at anti-sulfatide antibody–exposed paranodes.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To firmly establish that the observed disruptions to paranodal proteins were not partly a confounding consequence of structural dysfunction secondary to abnormal ganglioside profiles in the axonal compartment of transgenic Glial mice, a complement-fixing antibody against the myelin glycolipid sulfatide ( 27 ) was used to target the paranodal loop glial membrane in WT mice in order to look for similar perturbations. As seen with the anti-GM1 antibody in Glial mice, AnkB and Caspr1 immunostaining was lost/abnormal compared with uninjured control ( Supplemental Figure 4 ) at anti-sulfatide antibody–exposed paranodes.…”
Section: Resultsmentioning
confidence: 99%
“…This was generated by immunising ganglioside-deficient mice with ganglioside liposomes or ganglioside-mimicking Campylobacter jejuni lipo-oligosaccharide, as described previously (22). Mouse monoclonal IgG3 anti-sulfatide antibody was also used, and generated as previously described (27). The following antibodies were used for immunostaining studies to identify proteins and complement: mouse anti-AnkB (UC Davis/NIH NeuroMab Facility Cat# N105/17, RRID:AB_2877200; 1:300) , mouse anti-AnkG (Thermo Fisher Scientific Cat# 33-8800, RRID:AB_2533145; 1:100); rabbit anti-Caspr1 (gifted by Professor Peles, Weizmann Institute, Rehovot, Israel; 1:1000); FITC-labelled rabbit anti-C3c (Agilent Cat# Q036805, RRID:AB_11180931; 1:300); rabbit anti-gliomedin (Abcam Cat# ab24483, RRID:AB_2111616; 1:100); mouse anti-human C5b-9 (Agilent Cat# M0777, RRID:AB_2067162; 1:50); rabbit anti-Kv1.1 Alomone Labs Cat# APC-009, RRID:AB_2040144; 1:200); rat anti-MBP (Bio-Rad Cat# MCA409S, RRID:AB_325004; 1:500); mouse anti-pan Nav (pNav; Sigma-Aldrich #8809; RRID:AB_477552; 1:100); rabbit anti-Nav1.6 (Sigma-Aldrich Cat# S0438, RRID:AB_477480; 1:100); rabbit anti-pan neurofascin (anti-panNFasc; gifted from Professor Brophy, University of Edinburgh, Edinburgh, UK; 1:1000); mouse anti-phosphorylated neurofilament-H antibody (NFH, BioLegend #801602 clone SMI31; RRID:AB_2715851; 1:1500).…”
Section: Antibodies and Reagents The Majority Of Experiments Used The...mentioning
confidence: 99%
“…Anti-GM1 ganglioside antibody (DG2) and anti-GD1b antibody (MOG1) were used at 20 μg/ml. A new monoclonal anti-sulfatide antibody (GAMEG3) derived from mice inoculated with sulfatide-bearing liposomes was used to detect sulfatide (Meehan et al, 2018). The following primary antibodies were used: mouse anti-phosphorylated neurofilament-H antibody (NF-H, BioLegend; RRID:AB_2715851; 1:2000); rat anti-MBP (Bio-Rad; RRID:AB_325004; 1:500); mouse anti-pan Nav (Sigma-Aldrich; RRID:AB_477552; 1:100); mouse anti-ankyrin G (Thermo Fisher Scientific; RRID:AB_2533145; 1:100); rabbit anti-Caspr (gifted from Professor Peles, Weizmann Institute, Israel; 1:1500); rabbit anti-Kv1.1 (Alomone Laboratories; RRID:AB_2040144; 1:200); rabbit anti-Nav1.6 (Sigma-Aldrich; RRID:AB_477480; 1:100); rabbit anti-pan neurofascin (anti-pNFasc; gifted from Professor Brophy, University of Edinburgh, UK; 1:1000); and mouse anti-MAG antibody (gifted from Professor Brophy, University of Edinburgh, UK; 1:100).…”
Section: Methodsmentioning
confidence: 99%
“…Anti‐sulphatide and anti‐ganglioside antibody binding patterns at the peripheral nerve node of Ranvier. (a) This panel has been modified from Figure 4(a), Meehan et al (2018) ( https://doi.org/10.1016/j.jneuroim.2018.07.004) with permission under the Creative Commons CC‐BY licence ( http://creativecommons.org/licenses/by/4.0/). Anti‐sulphatide antibody binding along the myelin and at the paranodal loops (green, *) was observed in the peripheral nerves (magenta) of wild‐type mice, while no binding was detected in CST −/− mice, thus demonstrating the specificity of the antibody to sulphatide.…”
Section: Gangliosides and Other Glycolipids At The Node Of Ranviermentioning
confidence: 99%
“…Indeed, in the absence of sulphatide, loss of NF155 immunostaining suggests a role in tethering this key paranodal axo‐glial adhesion molecule to the glial membrane (Hoshi et al, 2007 ; McGonigal et al, 2019 ). However, only recently, owing to the development of new anti‐sulphatide antibodies, have immunolabelling studies shown that sulphatide appears highly enriched in paranodal loops, as well as being present along the Schwann cell membrane (Meehan et al, 2018 ) (Figure 3a ).…”
Section: Gangliosides and Other Glycolipids At The Node Of Ranviermentioning
confidence: 99%